Aquestive Therapeutics

AQSTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$494.340 M

$3.94 +0.51%

Close of 7 Aug 2026

Revenue

$44.5M

#2780 by revenue

Earnings

-$83.8M

Loss-making

Shares outstanding

122,045,049

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#209Tenax TherapeuticsTENX$503.0M
#210EvolusEOLS$501.3M
#211Aquestive TherapeuticsAQST$494.3M
#212Ovid TherapeuticsOVID$490.9M
#213Benitec BiopharmaBNTC$468.2M

Where these numbers come from

Share counts and financials for Aquestive Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.